急性脑梗死是由于血栓或栓子阻塞动脉血管致该动脉供应区的脑组织软化、坏死而产生的相应脑损害症状,因此早期使用溶栓药物,重建缺血区循环,减轻脑神经细胞及其功能损害,改善预后,提高生存质量已受到人们的高度关注。巴曲酶是新型强力单成分溶血栓微循环治疗剂,具有增强纤溶系 Acute cerebral infarction is due to thrombosis or emboli blockage caused by arterial blood vessels in the arterial supply area of ​​brain tissue softening and necrosis caused by the corresponding brain damage symptoms, so the early use of thrombolytic drugs, rebuilding the ischemic area of ​​circulation, reduce brain nerve cells and their Functional impairment, improve prognosis, improve the quality of life has been the people’s attention. Batroxobin is a new powerful single-component thrombolytic microcirculation therapy, with enhanced fibrinolysis